3-O-ALPHA-L-ARABINOFURANOSYL-(1->3)-[ALPHA-L-ARABINOFURANOSYL-(1->2)]-BETA-D-GLUCURONOPYRANOSYL-21-BETA,22-ALPHA-DI-O-ANGELOYL-PROTOAESCIGENIN
Compound with spectra: 1 NMR
![3-O-ALPHA-L-ARABINOFURANOSYL-(1->3)-[ALPHA-L-ARABINOFURANOSYL-(1->2)]-BETA-D-GLUCURONOPYRANOSYL-21-BETA,22-ALPHA-DI-O-ANGELOYL-PROTOAESCIGENIN](/api/compound/6C84hX8DqiH.png?ph=true&h=300&w=458 "3-O-ALPHA-L-ARABINOFURANOSYL-(1->3)-[ALPHA-L-ARABINOFURANOSYL-(1->2)]-BETA-D-GLUCURONOPYRANOSYL-21-BETA,22-ALPHA-DI-O-ANGELOYL-PROTOAESCIGENIN")
| SpectraBase Compound ID | 6C84hX8DqiH |
|---|---|
| InChI | InChI=1S/C56H86O22/c1-11-25(3)46(69)77-43-44(78-47(70)26(4)12-2)56(24-60)28(19-51(43,5)6)27-13-14-32-52(7)17-16-34(53(8,23-59)31(52)15-18-54(32,9)55(27,10)20-33(56)61)73-50-42(76-49-38(65)36(63)30(22-58)72-49)40(39(66)41(75-50)45(67)68)74-48-37(64)35(62)29(21-57)71-48/h11-13,28-44,48-50,57-66H,14-24H2,1-10H3,(H,67,68)/b25-11-,26-12-/t28-,29-,30-,31+,32+,33+,34-,35-,36-,37+,38+,39-,40-,41-,42+,43-,44-,48-,49-,50+,52-,53+,54+,55+,56-/m0/s1 |
| InChIKey | ZBOZFTPSFGOWCM-FVHLMCFHSA-N |
| Mol Weight | 1111.3 g/mol |
| Molecular Formula | C56H86O22 |
| Exact Mass | 1110.561074 g/mol |
| Enantiomer InChIKey | ZBOZFTPSFGOWCM-ZTXSVSGNSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
6H,13H-5,13:6,12-Dietheno-5a,12a-(methaniminomethano)-1H,5H,8H,12H-[1,2,4]triazolo[1,2-a][1,2,4]triazolo[1',2':1,2]pyridazino[4,5-d]pyridazine-18-acetic acid, 2,3,9,10-tetrahydro-.alpha.-(2-methylpropyl)-1,3,8,10,17,19-hexaoxo-2,9-diphenyl-, hexyl ester, stereoisomer
4H,6H,15H,17H-Tetrapyrano[2,3-f:2',3'-f':2'',3''-h:2''',3'''-h']cyclo buta[1,2-c:4,3-c']bis[1]benzopyran-4,17-dione, 10,10a,10b,11,20c,20d-hexahydro-2,6,6,10,10,11,11,15,15,19-decamethyl-, [10aS-(10a.alpha.,10b.beta.,20c.beta.,20d.alpha.)]-
41,42,43,44,45,46,47,48-Octamethoxy-4,9,14,19,24,29,34,39-octamethylnonacyclo[35.3.1.1(2,6).1(7,11).1(12,16).1(17,21).1(22,26).1(27,31).1(32,36)]octatetraconta-1(41),2,4,6(48),7,9,11(47),12,14,16(46),17,19,21(45),22,24,26(44),27,29,31(43),32,34,36(42),37,39-tetracosaene
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
Quamoclin II peracetate[(S)-Convolvulinoic acid 11-O.beta,-D-glucopyranosyl-(1-3)-O-[4-O-2(S)-methylbutyryl-.alpha.,L-rhamnopyranosyl-(1-4)]-O-(2-O-n-dodececanoyl).alpha.,L-rhamnopyranosyl-(1-4)-O-.alpha.-L-rhymnopyranosyl[-(1-2)-.beta.D-fucopyranoside peracetate]
38-(3,5-Dimethylphenyl)-7,8,19,20,28,29,35,36-octahydro-6H,10H,16H,32H,34H-59:17,21-dimethano-11,15-metheno-1,2,5-[1',3']pyrimidino-5H,27H-dibenzo[b,u][1,23,4,8,16,20]dioxatetraazcyclohexacosine-32,37,39-trione
38-(3,5-Dimethylphenyl)-7,8,19,20,28,29,35,36-octahydro-6H,10H,16H,32H,34H-59:17,21-dimethano-11,15-metheno-1,2,5-[1',3']pyrimidino-5H,27H-dibenzo[b,u][1,23,4,8,16,20]dioxatetraazacyclohexacosine-32,37,39-trione
Dispiro[piperidine-4,2'-[7,14,24,31]tetraoxapentacyclo[30.2.2.23,6.215,18.220,23]dotetraconta[3,5,15,17,20,22,32,34,35,37,39,41]dodecaen e-19',4''-piperidine], 1,1''-diacetyl-5',33'-dibromo-16',22',36',37',40',41'-hexamethyl-
[9,9'-Biphenanthrene]-5,5',8,8',10,10'(2H,2'H)-hexone, 1,1',3,3',4,4',4a,4'a,9,9',10a,10'a-dodecahydro-6,6'-dihydroxy-1,1,1' ,1',4a,4'a-hexamethyl-7,7'-bis(1-methylethyl)-, [4aS-[4a.alpha.,9.beta.(4'aR*,9'R*,10'aR*),10a.beta.]]-
Spiro[12,15:17,20-dietheno-6H,16H,22H-dibenzo[b,d][1,6,12,22]tetraox acycloheptacosin-16,4'-piperidine]-1,31-dimethanamine, 7,8,9,10,23,24,25,26-octahydro-N,N,N',N',1',13,19,32,35-nonamethyl-, (S)-
| Title | Journal or Book | Year |
|---|---|---|
| Haemolytic acylated triterpenoid saponins from Harpullia austro-caledonica | Phytochemistry | 2005 |